📊 Score Breakdown
Offering Ability
60
Cash Runway
0
Float Risk
22
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for TRVI.
💹 Market Data
Market Cap$1.94B
Shares Outstanding141.93M
Float105.98M
Cash$188.26M
Debt$753.0K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 0.7% shares (2025Q4 vs prior)
185 institutional holders · 133.54M shares
#1
NEA Management Company, LLC
13.22M shares
#2
Frazier Life Sciences Management, L.P.
10.26M shares
#3
BlackRock, Inc.
10.13M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest16.14M
Days to Cover13.4
% of Float15.2%
FINRA data as of Apr 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2019
4
INSIDER TRANSACTION
Feb 20, 2026
4
INSIDER TRANSACTION
Feb 20, 2026
4
INSIDER TRANSACTION
Feb 20, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for TRVI
📊 TRVI FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 TRVI Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.